http://jama.jamanetwork.com/ en-us Wed, 23 Jan 2013 00:00:00 GMT Tue, 22 Jan 2013 19:52:11 GMT Silverchair editor@jama.jamanetwork.com webmaster@jama.jamanetwork.com http://jama.jamanetwork.com/article.aspx?articleID=1558262 Wed, 23 Jan 2013 00:00:00 GMT Kuehn BM. <span class="paragraphSection">The US Food and Drug Administration (FDA) has received reports of serious skin reactions and systemic symptoms, including deaths, among patients taking telaprevir in combination with peginterferon alfa and ribavirin.</span> 309 4 333 333 10.1001/jama.2013.22 http://jama.jamanetwork.com/article.aspx?articleID=1558262